06.02.2013 Views

Monograph on the Potential Human Reproductive and ... - OEHHA

Monograph on the Potential Human Reproductive and ... - OEHHA

Monograph on the Potential Human Reproductive and ... - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

276 CHAPIN ET AL.<br />

tyrosine-hydroxlyase m<strong>on</strong>ocl<strong>on</strong>al antibody reactivity<br />

[number of rats not indicated]. Most statistical analyses<br />

were performed using ANOVA techniques. Activity data<br />

were analyzed using repeated measures ANOVA to<br />

examine activity in 2-hr intervals, as well as across <strong>the</strong><br />

dark, light, or full 24-hr period. Student t-tests were used<br />

to compare catecholamine levels.<br />

Sp<strong>on</strong>taneous motor activity in rats treated with bisphenol<br />

A increased in a dose-dependent manner over<br />

<strong>the</strong> 0.087–87 nmol range, with significance <strong>on</strong> pair-wise<br />

comparis<strong>on</strong> with c<strong>on</strong>trols at dose levels Z0.87 nmol [198<br />

ng]. Activity was increased in both <strong>the</strong> dark <strong>and</strong> light<br />

periods. Tyrosine hydroxylase activity was reduced in<br />

bisphenol A-treated rats, compared to c<strong>on</strong>trols. [Quantificati<strong>on</strong><br />

of immunohistochemical secti<strong>on</strong>s was not<br />

provided.] Gene expressi<strong>on</strong> patterns in <strong>the</strong> midbrain<br />

differed in bisphenol A <strong>and</strong> 6-hydroxydopamine-treated<br />

animals.<br />

The authors c<strong>on</strong>cluded that ne<strong>on</strong>atal exposure to<br />

bisphenol A was associated with an increase in sp<strong>on</strong>taneous<br />

motor activity <strong>and</strong> reduced tyrosine hydroxylase<br />

activity. They hypo<strong>the</strong>sized that bisphenol A may cause a<br />

deficit in <strong>the</strong> development of mesostriatal dopaminergic<br />

neur<strong>on</strong>s, <strong>and</strong> that this increase ei<strong>the</strong>r is greater than that<br />

produced by 6-hydroxydopamine lesi<strong>on</strong>s or involves<br />

additi<strong>on</strong>al neurochemical systems. A follow-up study<br />

(Masuo et al., 2004b) addressed <strong>the</strong>se issues. The authors<br />

also proposed that bisphenol A-exposed rats can serve as<br />

animal models of attenti<strong>on</strong> deficit-hyperactivity disorder.<br />

Strengths/Weaknesses: A significant weakness is <strong>the</strong><br />

inability to correlate <strong>the</strong> internal exposure to bisphenol A<br />

provided by <strong>the</strong> intracisternal route with that seen by <strong>the</strong><br />

oral route.<br />

Utility (Adequacy) for CERHR Evaluati<strong>on</strong> Process:<br />

This study is inadequate for <strong>the</strong> evaluati<strong>on</strong> process due<br />

to uncertainties around <strong>the</strong> intracisternal route of<br />

administrati<strong>on</strong>.<br />

Masuo et al. (2004b), funded by <strong>the</strong> New Energy <strong>and</strong><br />

Industrial Technology Development Organizati<strong>on</strong>, <strong>the</strong><br />

Ministry of <strong>the</strong> Envir<strong>on</strong>ment, <strong>and</strong> <strong>the</strong> Ministry of<br />

Ec<strong>on</strong>omy, Trade, <strong>and</strong> Industry, Japan, followed up <strong>the</strong>ir<br />

previous study (Masuo et al., 2004a) with additi<strong>on</strong>al gene<br />

expressi<strong>on</strong> microarrays to elucidate potential molecular<br />

pathways associated with <strong>the</strong> effects of an acute,<br />

ne<strong>on</strong>atal exposure to 6-hydroxydopamine, bisphenol A,<br />

n<strong>on</strong>ylphenol, diethylhexyl phthalate, or dibutyl<br />

phthalate <strong>on</strong> sp<strong>on</strong>taneous motor activity levels at 4–5<br />

weeks of age. Pregnant Wistar rats were housed in<br />

acrylic cages with free access to tap water <strong>and</strong> laboratory<br />

chow (Oriental Yeast) <strong>and</strong> maintained <strong>on</strong> a 12-hr light/<br />

12-hr dark cycle. In <strong>the</strong> 6-hydroxydopamine group,<br />

5-day-old male pups, each about 10 g, were first<br />

pretreated with 25 mg/kg desipramine by i.p. injecti<strong>on</strong><br />

(to protect noradrenergic neur<strong>on</strong>s from <strong>the</strong> effects of 6hydroxydopamine)<br />

<strong>and</strong> <strong>the</strong>n given 6-hydroxydopamine<br />

intracisternally 30 min later. PND 5 male pups in o<strong>the</strong>r<br />

groups were intracisternally injected with olive oil<br />

vehicle, 87 nM bisphenol A [19.8 lg] [purity not<br />

provided], n<strong>on</strong>ylphenol, diethylhexyl phthalate, or<br />

dibutyl phthalate. [Only <strong>the</strong> bisphenol A experiments<br />

will be discussed here.] Following treatments,<br />

pups were r<strong>and</strong>omly fostered to lactating dams (5–7<br />

pups/per dam) <strong>and</strong> weaned at 3 weeks of age. At 4–5<br />

weeks of age, <strong>the</strong> sp<strong>on</strong>taneous motor activity of bisphenol<br />

A treated rats was compared to vehicle treated<br />

rats (n 5 6 or 7/group) using an automated activitym<strong>on</strong>itoring<br />

system over a 12-hr light/12-hr dark cycle.<br />

Bisphenol A <strong>and</strong> vehicle-treated rats were killed at 8–10<br />

weeks of age <strong>and</strong> <strong>the</strong> striatum <strong>and</strong> midbrain were<br />

harvested. RNA was extracted from 2 pooled striata/rat<br />

(n 5 3/group) or 1 midbrain/rat (n 5 3/group) for cDNA<br />

microarray analyses. Gene expressi<strong>on</strong> values were<br />

evaluated relative to those of c<strong>on</strong>trol-treated rats.<br />

Repeated measures ANOVA was used for statistical<br />

analyses of sp<strong>on</strong>taneous motor activity during 2-hr<br />

time intervals. Statistics were not described for microarray<br />

results.<br />

Ne<strong>on</strong>atal exposure to bisphenol A in male rats<br />

increased sp<strong>on</strong>taneous motor activity significantly at 4–<br />

5 weeks during both <strong>the</strong> dark <strong>and</strong> light periods of <strong>the</strong><br />

cycle when compared to c<strong>on</strong>trols. Gene expressi<strong>on</strong><br />

profiles examined at 8–10 weeks of age for select genes<br />

potentially impinging <strong>on</strong> dopamine functi<strong>on</strong> <strong>and</strong>/or<br />

o<strong>the</strong>r pathways were altered in <strong>the</strong> adult striatum <strong>and</strong><br />

midbrain of bisphenol A treated mice. The authors<br />

c<strong>on</strong>cluded that ne<strong>on</strong>atal exposure to bisphenol A<br />

resulted in elevated sp<strong>on</strong>taneous motor activity during<br />

both <strong>the</strong> light <strong>and</strong> dark phases. 6-Hydroxydopamine<br />

lesi<strong>on</strong>s increased motor activity <strong>on</strong>ly during <strong>the</strong> dark<br />

period. Comparis<strong>on</strong>s of genetic expressi<strong>on</strong> in 6-hydroxydopamine<br />

<strong>and</strong> bisphenol A-treated rats suggested that<br />

<strong>the</strong> effects of bisphenol A may be mediated by alterati<strong>on</strong>s<br />

in dopamine as well as o<strong>the</strong>r systems. This profile of<br />

adverse effects was suggested to potentially serve as a<br />

model for human hyperactivity disorders.<br />

Strengths/Weaknesses: A significant weakness is <strong>the</strong><br />

inability to correlate <strong>the</strong> internal exposure to bisphenol A<br />

provided by <strong>the</strong> intracisternal route with that seen by <strong>the</strong><br />

oral route.<br />

Utility (Adequacy) for CERHR Evaluati<strong>on</strong> Process:<br />

This study is inadequate for <strong>the</strong> evaluati<strong>on</strong> process due<br />

to uncertainties around <strong>the</strong> intracisternal route of<br />

administrati<strong>on</strong>.<br />

Ishido et al. (2005), support not indicated, examined<br />

<strong>the</strong> effects of ne<strong>on</strong>atal bisphenol A exposure of rats <strong>on</strong><br />

motor activity <strong>and</strong> gene expressi<strong>on</strong> in brain. Wistar rat<br />

dams were fed MF diet (Oriental Yeast). Pups were born<br />

from 10 pregnant dams <strong>and</strong> 5–7 male pups were assigned<br />

to each dam. At 5 days of age, male pups were injected<br />

intracisternally with vehicle (50% ethanol in olive oil) or<br />

87 nmol [19.8 lg] bisphenol A. [No informati<strong>on</strong> was<br />

provided <strong>on</strong> number of pups treated, purity of bisphenol<br />

A, or caging <strong>and</strong> bedding materials.] Pups were<br />

also treated with 2 n<strong>on</strong>ylphenol compounds <strong>and</strong> 3<br />

phthalate compounds, but results for those compounds<br />

will not be discussed. Pups were weaned at 3 weeks of<br />

age. Sp<strong>on</strong>taneous motor activity was measured in pups<br />

at 4–5 weeks of age. Rats were killed at 8 weeks of age,<br />

<strong>and</strong> RNA was isolated from midbrain for microarray<br />

analyses of gene expressi<strong>on</strong>. [The number of rats<br />

examined was not reported for any endpoint.] Data<br />

for sp<strong>on</strong>taneous motor activity were analyzed by<br />

ANOVA or Student t-test. [There were no statistical<br />

analyses for gene expressi<strong>on</strong> data.]<br />

Rats exposed to bisphenol A were significantly more<br />

active during <strong>the</strong> nocturnal phase than c<strong>on</strong>trol rats (by<br />

B1.4–1.6-fold). In midbrains of 8-week-old rats, expressi<strong>on</strong><br />

levels were altered for 46 G protein-coupled receptor<br />

genes, which are involved in dopaminergic neurotransducti<strong>on</strong><br />

<strong>and</strong> many peptidergic neurotransducti<strong>on</strong><br />

Birth Defects Research (Part B) 83:157–395, 2008

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!